Intrauterine growth restriction – part 1

Bibliography

• Battaglia FC, Lubchenco LO. A practical classification of newborn infants by weight and gestational age. J Pediatr 1967;71:159–63
   PubMed Web of Science ®Google Scholar
• de Onis M, Blössner M, Villar J. Levels and patterns of intrauterine growth retardation in developing countries. Eur J Clin Nutr 1998;52 Suppl:S5–15
   PubMedGoogle Scholar
• Figueras F, Gardosi J. Intrauterine growth restriction: new concepts in antenatal surveillance, diagnosis, and management. Am J Obstet Gynecol 2011;204:288–300
   PubMed Web of Science ®Google Scholar
• Platz E, Newman R. Diagnosis of IUGR: traditional biometry. Semin Perinatol 2008;32:140–7
   PubMed Web of Science ®Google Scholar
• Dashe JS, McIntire DD, Lucas MJ, Leveno KJ. Effects of symmetric and asymmetric fetal growth on pregnancy outcomes. Obstet Gynecol 2000;96:321–7
   PubMed Web of Science ®Google Scholar
• Bernstein PS, Divon MY. Etiologies of fetal growth restriction. Clin Obstet Gynecol 1997;40:723–9
   PubMed Web of Science ®Google Scholar
• Fang J, Madhavan S, Alderman MH. Low birth weight: race and maternal nativity-impact of community income. Pediatrics 1999;103:E5
   PubMed Web of Science ®Google Scholar
• Strobino DM, Ensminger ME, Kim YJ, Nanda J. Mechanisms for maternal age differences in birth weight. Am J Epidemiol 1995;142:504–14
   PubMed Web of Science ®Google Scholar
• Wilcox MA, Smith SJ, Johnson IR, et al. The effect of social deprivation on birthweight, excluding physiological and pathological effects. Br J Obstet Gynaecol 1995;102:918–24
   PubMedGoogle Scholar
• Hendrix N, Berghella V. Non-placental causes of intrauterine growth restriction. Semin Perinatol 2008;32:161–5
   PubMed Web of Science ®Google Scholar
• Schieve LA, Meikle SF, Ferre C, et al. Low and very low birth weight in infants conceived with use of assisted reproductive technology. N Engl J Med 2002;346:731–7
   PubMed Web of Science ®Google Scholar
• Nomura RMY, Paiva LV, Costa VN, et al. [Influence of maternal nutritional status, weight gain and energy intake on fetal growth in high-risk pregnancies]. Rev Bras Ginecol Obstet Obstetrícia Fed Soc E 2012;34:107–12
   PubMedGoogle Scholar
• Zhu BP, Rolfs RT, Nangle BE, Horan JM. Effect of the interval between pregnancies on perinatal outcomes. N Engl J Med 1999;340:589–94
   PubMed Web of Science ®Google Scholar
• Andres RL, Day MC. Perinatal complications associated with maternal tobacco use. Semin Neonatol 2000;5:231–41
   PubMedGoogle Scholar
• Kharrazi M, DeLorenze GN, Kaufman FL, et al. Environmental tobacco smoke and pregnancy outcome. Epidemiology Camb 2004;15:660–70
   PubMed Web of Science ®Google Scholar
• Hanke W, Sobala W, Kalinka J. Environmental tobacco smoke exposure among pregnant women: impact on fetal biometry at 20-24 weeks of gestation and newborn child's birth weight. Int Arch Occup Environ Health 2004;77:47–52
   PubMed Web of Science ®Google Scholar
• Haddon W, Nesbitt RE, Garcia R. Smoking and pregnancy: carbon monoxide in blood during gestation and at term. Obstet Gynecol 1961;18:262–7
   PubMed Web of Science ®Google Scholar
• Newnham JP, Patterson L, James I, Reid SE. Effects of maternal cigarette smoking on ultrasonic measurements of fetal growth and on Doppler flow velocity waveforms. Early Hum Dev 1990;24:23–36
   PubMed Web of Science ®Google Scholar
• Goel P, Radotra A, Singh I, et al. Effects of passive smoking on outcome in pregnancy. J Postgrad Med 2004;50:12–16
   PubMedGoogle Scholar
• Norsa’adah B, Salinah O. The Effect of Second-Hand Smoke Exposure during Pregnancy on the Newborn Weight in Malaysia. Malays J Med Sci MJMS 2014;21:44–53
   PubMedGoogle Scholar
• Lundsberg LS, Bracken MB, Saftlas AF. Low-to-moderate gestational alcohol use and intrauterine growth retardation, low birthweight, and preterm delivery. Ann Epidemiol 1997;7:498–508
   PubMed Web of Science ®Google Scholar
• Yang Q, Witkiewicz BB, Olney RS, et al. A case-control study of maternal alcohol consumption and intrauterine growth retardation. Ann Epidemiol 2001;11:497–503
   PubMed Web of Science ®Google Scholar
• Wen SW, Zhou J, Yang Q, et al. Maternal exposure to folic acid antagonists and placenta-mediated adverse pregnancy outcomes. CMAJ Can Med Assoc J J Assoc Medicale Can 2008;179:1263–8
   PubMed Web of Science ®Google Scholar
• Zuckerman B, Frank DA, Hingson R, et al. Effects of maternal marijuana and cocaine use on fetal growth. N Engl J Med 1989;320:762–8
   PubMed Web of Science ®Google Scholar
• Krampl E. Pregnancy at high altitude. Ultrasound Obstet Gynecol 2002;19:535–9
   PubMed Web of Science ®Google Scholar
• Murki S, Sharma D. Intrauterine growth retardation – a review article. J Neonatal Biol [Internet] 2014;03: [cited 2015 May 29];Available from: http://www.omicsgroup.org/journals/intrauterine-growth-retardation-a-review-article-2167-0897.1000135.php?aid=25766
   Google Scholar
• Heinonen S, Taipale P, Saarikoski S. Weights of placentae from small-for-gestational age infants revisited. Placenta 2001;22:399–404
   PubMed Web of Science ®Google Scholar
• Yu KM. [Relation between placental morphometry and fetal growth]. Zhonghua Fu Chan Ke Za Zhi 1992;27:217–9, 250
   PubMedGoogle Scholar
• Zygmunt M. Placental circulation: clinical significance. Early Pregnancy Online 2001;5:72–3
   PubMedGoogle Scholar
• Zygmunt M, Herr F, Münstedt K, et al. Angiogenesis and vasculogenesis in pregnancy. Eur J Obstet Gynecol Reprod Biol 2003;110 Suppl:S10–18
   PubMedGoogle Scholar
• Bjøro K. Vascular anomalies of the umbilical cord: I. Obstetric implications. Early Hum Dev 1983;8:119–27
   PubMed Web of Science ®Google Scholar
• Bjøro K. Gross pathology of the placenta in intrauterine growth retardation. Ann Chir Gynaecol 1981;70:316–22
   PubMedGoogle Scholar
• Djakovic A, Rieger L, Wirbelauer J, et al. [Severe foetal growth retardation in a patient with uterus bicornis, velamentous insertion and partial placental abruption in the 26th week of gestation–a case report]. Z Für Geburtshilfe Neonatol 2007;211:169–73
   PubMedGoogle Scholar
• Conroy AL, Silver KL, Zhong K, et al. Complement activation and the resulting placental vascular insufficiency drives fetal growth restriction associated with placental malaria. Cell Host Microbe 2013;13:215–26
   PubMed Web of Science ®Google Scholar
• Wilkins-Haug L, Quade B, Morton CC. Confined placental mosaicism as a risk factor among newborns with fetal growth restriction. Prenat Diagn 2006;26:428–32
   PubMed Web of Science ®Google Scholar
• Stipoljev F, Latin V, Kos M, et al. Correlation of confined placental mosaicism with fetal intrauterine growth retardation. A case control study of placentas at delivery. Fetal Diagn Ther 2001;16:4–9
   PubMed Web of Science ®Google Scholar
• Robinson WP, Peñaherrera MS, Jiang R, et al. Assessing the role of placental trisomy in preeclampsia and intrauterine growth restriction. Prenat Diagn 2010;30:1–8
   PubMed Web of Science ®Google Scholar
• Boog G. Chronic villitis of unknown etiology. Eur J Obstet Gynecol Reprod Biol 2008;136:9–15
   PubMed Web of Science ®Google Scholar
• Szentpéteri I, Rab A, Kornya L, et al. Placental gene expression patterns of endoglin (CD105) in intrauterine growth restriction. J Matern-Fetal Neonatal Med 2014;27:350–4
   PubMed Web of Science ®Google Scholar
• Szentpéteri I, Rab A, Kornya L, et al. Gene expression patterns of vascular endothelial growth factor (VEGF-A) in human placenta from pregnancies with intrauterine growth restriction. J Matern-Fetal Neonatal Med 2013;26:984–9
   PubMed Web of Science ®Google Scholar
• Snijders RJ, Sherrod C, Gosden CM, Nicolaides KH. Fetal growth retardation: associated malformations and chromosomal abnormalities. Am J Obstet Gynecol 1993;168:547–55
   PubMed Web of Science ®Google Scholar
• Anandakumar C, Chew S, Wong YC, et al. Early asymmetric IUGR and aneuploidy. J Obstet Gynaecol Res 1996;22:365–70
   PubMedGoogle Scholar
• Soong Y-K, Wang T-H, Lee Y-S, et al. Genome-wide detection of uniparental disomy in a fetus with intrauterine growth restriction using genotyping microarrays. Taiwan J Obstet Gynecol 2009;48:152–8
   PubMed Web of Science ®Google Scholar
• Rochelson B, Kaplan C, Guzman E, et al. A quantitative analysis of placental vasculature in the third-trimester fetus with autosomal trisomy. Obstet Gynecol 1990;75:59–63
   PubMed Web of Science ®Google Scholar
• Wallenstein MB, Harper LM, Odibo AO, et al. Fetal congenital heart disease and intrauterine growth restriction: a retrospective cohort study. J Matern-Fetal Neonatal Med 2012;25:662–5
   PubMed Web of Science ®Google Scholar
• Balayla J, Abenhaim HA. Incidence, predictors and outcomes of congenital diaphragmatic hernia: a population-based study of 32 million births in the United States. J Matern-Fetal Neonatal Med 2014;27:1438–44
   PubMed Web of Science ®Google Scholar
• Khoury MJ, Erickson JD, Cordero JF, McCarthy BJ. Congenital malformations and intrauterine growth retardation: a population study. Pediatrics 1988;82:83–90
   PubMed Web of Science ®Google Scholar
• Khan NA, Kazzi SN. Yield and costs of screening growth-retarded infants for torch infections. Am J Perinatol 2000;17:131–5
   PubMed Web of Science ®Google Scholar
• Steketee RW, Nahlen BL, Parise ME, Menendez C. The burden of malaria in pregnancy in malaria-endemic areas. Am J Trop Med Hyg 2001;64:28–35
   PubMed Web of Science ®Google Scholar
• Walker PGT, ter Kuile FO, Garske T, et al. Estimated risk of placental infection and low birthweight attributable to Plasmodium falciparum malaria in Africa in 2010: a modelling study. Lancet Glob Health 2014;2:e460–7
   PubMed Web of Science ®Google Scholar
• Singh N, Singh MP, Wylie BJ, et al. Malaria prevalence among pregnant women in two districts with differing endemicity in Chhattisgarh, India. Malar J 2012;11:274
   PubMed Web of Science ®Google Scholar
• Rogerson SJ, Grau GE, Hunt NH. The microcirculation in severe malaria. Microcirculation 2004;11:559–76
   PubMed Web of Science ®Google Scholar
• Priyadarshi A, Verge CF, Vandervliet L, et al. Transient Neonatal Diabetes Mellitus followed by recurrent asymptomatic hypoglycaemia: a case report. BMC Pediatr 2015;15:200
   PubMed Web of Science ®Google Scholar
• Lewi L, Gucciardo L, Huber A, et al. Clinical outcome and placental characteristics of monochorionic diamniotic twin pairs with early- and late-onset discordant growth. Am J Obstet Gynecol 2008;199:511.e1–7
   PubMed Web of Science ®Google Scholar
• Wee L. Very-early-onset discordant growth in monochorionic twin pregnancy. Obstet Gynecol 2004;104:412 author reply 413
   PubMed Web of Science ®Google Scholar
• Fieni S, Gramellini D. Very-early-onset discordant growth in monochorionic twin pregnancy. Obstet Gynecol 2004;103:1115–17
   PubMed Web of Science ®Google Scholar
• Murthi P. Review: placental homeobox genes and their role in regulating human fetal growth. Placenta 2014;35 Suppl:S46–50
   PubMedGoogle Scholar
• Murthi P, Doherty V, Said J, et al. Homeobox gene HLX1 expression is decreased in idiopathic human fetal growth restriction. Am J Pathol 2006;168:511–18
   PubMed Web of Science ®Google Scholar
• Murthi P, Abumaree M, Kalionis B. Analysis of homeobox gene action may reveal novel angiogenic pathways in normal placental vasculature and in clinical pregnancy disorders associated with abnormal placental angiogenesis. Front Pharmacol 2014;5:133
   PubMed Web of Science ®Google Scholar
• Murthi P, Rajaraman G, Brennecke SP, Kalionis B. The role of placental homeobox genes in human fetal growth restriction. J Pregnancy 2011;2011:548171
   PubMedGoogle Scholar
• Murthi P, Doherty VL, Said JM, et al. Homeobox gene ESX1L expression is decreased in human pre-term idiopathic fetal growth restriction. Mol Hum Reprod 2006;12:335–40
   PubMed Web of Science ®Google Scholar
• Chelbi ST, Wilson ML, Veillard A-C, et al. Genetic and epigenetic mechanisms collaborate to control SERPINA3 expression and its association with placental diseases. Hum Mol Genet 2012;21:1968–78
   PubMed Web of Science ®Google Scholar
• Gascoin-Lachambre G, Buffat C, Rebourcet R, et al. Cullins in human intra-uterine growth restriction: expressional and epigenetic alterations. Placenta 2010;31:151–7
   PubMed Web of Science ®Google Scholar
• van Dijk M, Oudejans CBM. STOX1: Key Player in Trophoblast Dysfunction Underlying Early Onset Preeclampsia with Growth Retardation. J Pregnancy [Internet] 2011; [cited 2015 Dec 16];2011. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3066643/
   PubMedGoogle Scholar
• Gremlich S, Damnon F, Reymondin D, et al. The long non-coding RNA NEAT1 is increased in IUGR placentas, leading to potential new hypotheses of IUGR origin/development. Placenta 2014;35:44–9
   PubMed Web of Science ®Google Scholar
• Li S-W, Ling Y, Jin S, et al. Expression of soluble vascular endothelial growth factor receptor-1 and placental growth factor in fetal growth restriction cases and intervention effect of tetramethylpyrazine. Asian Pac J Trop Med 2014;7:663–7
   PubMed Web of Science ®Google Scholar
• Vrachnis N, Kalampokas E, Sifakis S, et al. Placental growth factor (PlGF): a key to optimizing fetal growth. J Matern-Fetal Neonatal Med 2013;26:995–1002
   PubMed Web of Science ®Google Scholar
• Mouillet J-F, Chu T, Hubel CA, et al. The levels of hypoxia-regulated microRNAs in plasma of pregnant women with fetal growth restriction. Placenta 2010;31:781–4
   PubMed Web of Science ®Google Scholar
• Tang Q, Wu W, Xu X, et al. miR-141 contributes to fetal growth restriction by regulating PLAG1 expression. PloS One 2013;8:e58737
   PubMed Web of Science ®Google Scholar
• Huang L, Shen Z, Xu Q, et al. Increased levels of microRNA-424 are associated with the pathogenesis of fetal growth restriction. Placenta 2013;34:624–7
   PubMed Web of Science ®Google Scholar
• Börzsönyi B, Demendi C, Rigó J, et al. The regulation of apoptosis in intrauterine growth restriction: a study of Bcl-2 and Bax gene expression in human placenta. J Matern-Fetal Neonatal Med 2013;26:347–50
   PubMed Web of Science ®Google Scholar
• Börzsönyi B, Demendi C, Nagy Z, et al. Gene expression patterns of insulin-like growth factor 1, insulin-like growth factor 2 and insulin-like growth factor binding protein 3 in human placenta from pregnancies with intrauterine growth restriction. J Perinat Med 2011;39:701–7
   PubMed Web of Science ®Google Scholar
• Lee MH, Jeon YJ, Lee SM, et al. Placental gene expression is related to glucose metabolism and fetal cord blood levels of insulin and insulin-like growth factors in intrauterine growth restriction. Early Hum Dev 2010;86:45–50
   PubMed Web of Science ®Google Scholar
• Rab A, Szentpéteri I, Kornya L, et al. Placental gene expression patterns of epidermal growth factor in intrauterine growth restriction. Eur J Obstet Gynecol Reprod Biol 2013;170:96–9
   PubMed Web of Science ®Google Scholar
• Arslan M, Yazici G, Erdem A, et al. Endothelin 1 and leptin in the pathophysiology of intrauterine growth restriction. Int J Gynaecol Obstet off Organ Int Fed Gynaecol Obstet 2004;84:120–6
   PubMed Web of Science ®Google Scholar
• Nezar MA-S, el-Baky AMA, Soliman OA-S, et al. Endothelin-1 and leptin as markers of intrauterine growth restriction. Indian J Pediatr 2009;76:485–8
   PubMed Web of Science ®Google Scholar
• Malamitsi-Puchner A, Briana DD, Boutsikou M, et al. Perinatal circulating visfatin levels in intrauterine growth restriction. Pediatrics 2007;119:e1314–18
   PubMed Web of Science ®Google Scholar
• Rajewski M, Skrzypczak J. [Frequency of antiphospholipid antibodies and factor V (G1691A), prothrombin (G20210A) gene polimorphism among women with pregnancy complications]. Pol Arch Med Wewnętrznej 2006;115:417–25
   PubMedGoogle Scholar
• Grandone E, Margaglione M, Colaizzo D, et al. Lower birth-weight in neonates of mothers carrying factor V G1691A and factor II A(20210) mutations. Haematologica 2002;87:177–81
   PubMed Web of Science ®Google Scholar
• Florio P, Marinoni E, Di Iorio R, et al. Urinary S100B protein concentrations are increased in intrauterine growth-retarded newborns. Pediatrics 2006;118:e747–54
   PubMed Web of Science ®Google Scholar
• Briana DD, Boutsikou M, Baka S, et al. N-terminal parathyroid hormone-related protein levels in human intrauterine growth restricted pregnancies. Acta Obstet Gynecol Scand 2007;86:945–9
   PubMed Web of Science ®Google Scholar
• Caliebe J, Broekman S, Boogaard M, et al. IGF1, IGF1R and SHOX mutation analysis in short children born small for gestational age and short children with normal birth size (idiopathic short stature). Horm Res Pædiatrics 2012;77:250–60
   PubMed Web of Science ®Google Scholar
• Kawashima Y, Higaki K, Fukushima T, et al. Novel missense mutation in the IGF-I receptor L2 domain results in intrauterine and postnatal growth retardation. Clin Endocrinol (Oxf) 2012;77:246–54
   PubMed Web of Science ®Google Scholar
• Leal AC, Montenegro LR, Saito RF, et al. Analysis of the insulin-like growth factor 1 receptor gene in children born small for gestational age: in vitro characterization of a novel mutation (p.Arg511Trp). Clin Endocrinol (Oxf) 2013;78:558–63
   PubMed Web of Science ®Google Scholar
• Leal A, de C, Canton APM, et al. [Mutations in insulin-like growth factor receptor 1 gene (IGF1R) resulting in intrauterine and postnatal growth retardation]. Arq Bras Endocrinol Metabol 2011;55:541–9
   PubMed Web of Science ®Google Scholar
• Fowden AL, Forhead AJ. Endocrine mechanisms of intrauterine programming. Reproduction Camb Engl 2004;127:515–26
   PubMed Web of Science ®Google Scholar
• Carver TD, Anderson SM, Aldoretta PA, et al. Glucose suppression of insulin secretion in chronically hyperglycemic fetal sheep. Pediatr Res 1995;38:754–62
   PubMed Web of Science ®Google Scholar
• Osmanağaoğlu MA, Osmanağaoğlu S, Bozkaya H. The association of birth weight with maternal and cord serum and amniotic fluid growth hormone and insulin levels, and with neonatal and maternal factors in pregnant women who delivered at term. J Perinat Med 2005;33:149–55
   PubMed Web of Science ®Google Scholar
• AJ DErcole, Z D, Y X, et al. Brain growth retardation due to the expression of human insulin like growth factor binding protein-1 in transgenic mice: an in vivo model for the analysis of IGF function in the brain. Brain Res Dev Brain Res 1994;82:213–22
   PubMedGoogle Scholar
• Ye P, Carson J, D’Ercole AJ. In vivo actions of insulin-like growth factor-I (IGF-I) on brain myelination: studies of IGF-I and IGF binding protein-1 (IGFBP-1) transgenic mice. J Neurosci off J Soc Neurosci 1995;15:7344–56
   PubMed Web of Science ®Google Scholar
• Delhanty PJ, Han VK. The expression of insulin-like growth factor (IGF)-binding protein-2 and IGF-II genes in the tissues of the developing ovine fetus. Endocrinology 1993;132:41–52
   PubMed Web of Science ®Google Scholar
• Wood TL, Rogler L, Streck RD, et al. Targeted disruption of IGFBP-2 gene. Growth Regul 1993;3:5–8
   PubMedGoogle Scholar
• Hill JM, Agoston DV, Gressens P, McCune SK. Distribution of VIP mRNA and two distinct VIP binding sites in the developing rat brain: relation to ontogenic events. J Comp Neurol 1994;342:186–205
   PubMed Web of Science ®Google Scholar
• Saki F, Dabbaghmanesh MH, Ghaemi SZ, et al. Thyroid function in pregnancy and its influences on maternal and fetal outcomes. Int J Endocrinol Metab 2014;12:e19378
   PubMedGoogle Scholar
• Sahu MT, Das V, Mittal S, et al. Overt and subclinical thyroid dysfunction among Indian pregnant women and its effect on maternal and fetal outcome. Arch Gynecol Obstet 2010;281:215–20
   PubMed Web of Science ®Google Scholar
• Murphy VE, Smith R, Giles WB, Clifton VL. Endocrine regulation of human fetal growth: the role of the mother, placenta, and fetus. Endocr Rev 2006;27:141–69
   PubMed Web of Science ®Google Scholar
• Fowden AL. Endocrine regulation of fetal growth. Reprod Fertil Dev 1995;7:351–63
   PubMed Web of Science ®Google Scholar
• GRIT Study Group A randomised trial of timed delivery for the compromised preterm fetus: short term outcomes and Bayesian interpretation. BJOG Int J Obstet Gynaecol 2003;110:27–32
   PubMed Web of Science ®Google Scholar
• Illanes S, Soothill P. Management of fetal growth restriction. Semin Fetal Neonatal Med 2004;9:395–401
   PubMedGoogle Scholar
• Small-for-Gestational-Age Fetus, Investigation and Management (Green-top Guideline No. 31) [Internet]. Royal College of Obstetricians & Gynaecologists. [cited 2015 Dec 17]. Available from: https://www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg31/
   Google Scholar
• Miller J, Turan S, Baschat AA. Fetal growth restriction. Semin Perinatol 2008 Aug;32:274–80
   PubMed Web of Science ®Google Scholar
• Bhutta ZA, Das JK, Bahl R, et al. Can available interventions end preventable deaths in mothers, newborn babies, and stillbirths, and at what cost? Lancet Lond Engl 2014;384:347–70
   PubMed Web of Science ®Google Scholar
• Ota E, Hori H, Mori R, et al. Antenatal dietary education and supplementation to increase energy and protein intake. Cochrane Database Syst Rev 2015;6:CD000032
   Google Scholar
• Haider BA, Bhutta ZA. Multiple-micronutrient supplementation for women during pregnancy. Cochrane Database Syst Rev 2015;11:CD004905
   PubMed Web of Science ®Google Scholar
• Jabeen M, Yakoob MY, Imdad A, Bhutta ZA. Impact of interventions to prevent and manage preeclampsia and eclampsia on stillbirths. BMC Public Health 2011;11:S6
   PubMed Web of Science ®Google Scholar
• Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2007;2:CD004659
   PubMed Web of Science ®Google Scholar
• Lumley J, Chamberlain C, Dowswell T, et al. Interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev 2009;3:CD001055
   PubMed Web of Science ®Google Scholar
• Singh M. Disorders of weight and gestation. In Care of the Newborn. 5th ed. Sagar Publications: New Delhi; 1999: 224–45
   Google Scholar